Current Status of Allogeneic Hematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 6, 2009, Pages 656-661

  Matos Fernandez, Nelson A ^a,b   Abou Mourad, Yasser R ^c   Caceres, William ^b   Kharfan Dabaja, Mohamed A ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Veterans Affairs Caribbean Healthcare System   (Puerto Rico)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Paroxysmal nocturnal hemoglobinuria

Indexed keywords

ANTICOAGULANT AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DANAZOL; ECULIZUMAB; FLUDARABINE; GLUCOCORTICOID; HEMOGLOBIN; IRON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROCARBAZINE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHRONIC GRAFT VERSUS HOST DISEASE; DIAGNOSTIC TEST; DISEASE COURSE; ERYTHROCYTE TRANSFUSION; HUMAN; IRON DEFICIENCY; MORTALITY; MYELOABLATIVE CONDITIONING; NONMYELOABLATIVE CONDITIONING; PANCYTOPENIA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PROGNOSIS; QUALITY OF LIFE; REDUCED INTENSITY CONDITIONING; REMISSION; REVIEW; SYMPTOM; THROMBOSIS;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; ANTIGENS, CD55; ANTIGENS, CD59; BLOOD TRANSFUSION; CHILD; CLINICAL TRIALS AS TOPIC; DANAZOL; GLUCOCORTICOIDS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; MIDDLE AGED; MYELOABLATIVE AGONISTS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; REMISSION INDUCTION; RISK FACTORS; THROMBOPHILIA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 67349143377     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.12.507     Document Type: Review

References (34)

1. Crosby W.H. Paroxysmal nocturnal hemoglobinuria: a classic description by Paul Strubing in 1882, and bibliography of the disease. Blood 6 (1951) 270-284
2. Socie G., Mary J.Y., De Gramont A., et al. Paroxysmal nocturnal hemoglobinuria: long-term follow-up and prognostic factors. Lancet 348 (1996) 573-577
3. Hillmen P., Lewis S.M., Bessler M., and Luzzatto L. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 333 (1995) 1253-1258
4. Nara K., Blessler M., Deeg H.J., and Luzzatto L. New somatic mutation in the PIG-A gene emerges at relapse of paroxysmal nocturnal hemoglobinuria. Blood 92 (1998) 3422-3427
5. de Latour R.P., Mary J.Y., Salanoubat C., et al. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 112 (2008) 3099-3106
6. Brodsky R.A. Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria. Blood Rev 22 (2008) 65-74
7. Hall S.E., and Rosse W.F. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 87 (1996) 5332-5340
8. Thomas T.C., Rollins S.A., Rother R.P., et al. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol Immunol 33 (1996) 1389-1401
9. Hillmen P., Young N.S., Schubert J., et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 355 (2006) 1233-1243
10. Brodsky R.A., Young N.S., Antonioli E., et al. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood 111 (2008) 1840-1847
11. Rosse W.F., and Nishimura J. Clinical manifestations of paroxysmal nocturnal hemoglobinuria: present state and future problems. Int J Hematol 77 (2003) 113-120
12. Hill A., Richards S.J., and Hillmen P. Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria. Br J Haematol 137 (2007) 181-192
13. Gluckman E., Devergie A., Dutreix A., et al. Bone marrow grafting in aplasic anemia after conditioning with cyclophosphamide and total body irradiation with lung shielding. Haematol Blood Transfus 25 (1980) 339-347
14. Ham T.H. Studies on destruction of red blood cells: I. chronic hemolyitic anemia with paroxysmal nocturnal hemoglobinuria: an investigation of the mechanism of hemolysis, with observation on five cases. Arch Intern Med 64 (1939) 1271
15. Hartmann R.C., and Jenkins D.E. The "sugar-water" test for paroxysmal nocturnal hemoglobinuria. N Engl J Med 275 (1966) 155-157
16. Richards S.J., Rawstron A.C., and Hillmen P. Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry 42 (2000) 223-233
17. Rosse W.F. Transfusion in paroxysmal nocturnal hemoglobinuria. To wash or not to wash?. Transfusion 29 (1989) 663-634
18. Harrington Sr. W.J., Kolodny L., Horstman L.L., and Ahn Y.S. Danazol for paroxysomal nocturnal hemoglobinuria. Am J Hematol 54 (1997) 149-154
19. Katayama Y., Hiramatsu Y., and Kohriyama K. Monitoring of CD59 expression in paroxysmal nocturnal hemoglobinuria treated with danazol. Am J Hematol 68 (2001) 280-283
20. Hall C., Richards S., and Hillmen P. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood 102 (2003) 3587-3591
21. Szer J., Deeg J., Witherspoon R., et al. Long-term survival after marrow transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemia. Ann Intern Med 101 (1984) 193-195
22. Antin J.H., Ginsburg D., Smith B.R., Nathan D.G., Orkin S.H., and Rappeport J.M. Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment. Blood 66 (1985) 1247-1250
23. Takahashi Y., McCoy Jr. J.P., Carvallo C., et al. In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation. Blood 103 (2004) 1383-1390
24. Bemba M., Guardiola P., Garderet L., et al. Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria. Br J Haematol 105 (1999) 366-368
25. Saso R., Marsh J., Cevreska L., et al. Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Br J Haematol 104 (1999) 392-396
26. Raiola A.M., Lint V., Lamparelli T., et al. Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. Haematologica 85 (2000) 59-62
27. Kawahara K., Witherspoon R.P., and Storb R. Marrow transplantation for paroxysmal nocturnal hemoglobinuria. Am J Hematol 39 (1992) 283-288
28. Lee J.L., Lee J.H., Lee J.H., et al. Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria. Eur J Haematol 71 (2003) 114-118
29. Woodward P., Wang W., Pitts N., et al. Succesful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. Bone Marrow Transplant 27 (2001) 589-592
30. Flotho C., Strahm B., Kontny U., et al. Stem cell transplantation for paroxysmal nocturnal haemoglobinuria in childhood. Br J Haematol 118 (2002) 124-127
31. Hegenbart U., Niederwieser D., Forman S., et al. Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant 9 (2003) 689-697
32. Brodsky R.A., Luznik L., Bolanos-Meade J., et al. Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases. Bone Marrow Transplant 42 (2008) 523-527
33. Kharfan-Dabaja M.A., Anasetti C., and Santos E.S. Hematopoietic cell transplantation for chronic lymphocytic leukemia: an evolving concept. Biol Blood Marrow Transplant 13 (2007) 373-385
34. de Lima M., Anagnostopoulos A., Munsell M., et al. Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation. Blood 104 (2004) 865-872